Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion type Assertion NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_head.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion evidence source_evidence_literature NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion SIO_000772 17009404 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion wasDerivedFrom lhgdn-20090331 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion wasGeneratedBy ECO_0000203 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.